Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000488174 | SCV000491492 | likely benign | not provided | 2020-12-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29228253) |
Ce |
RCV000488174 | SCV000575064 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4 |
Eurofins Ntd Llc |
RCV000488174 | SCV000703606 | uncertain significance | not provided | 2016-12-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000488174 | SCV002475552 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278643 | SCV002565283 | likely benign | Ehlers-Danlos syndrome | 2021-08-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402101 | SCV002706461 | benign | Cardiovascular phenotype | 2021-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003137993 | SCV003821857 | uncertain significance | Brittle cornea syndrome 1 | 2022-06-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902458 | SCV004723391 | uncertain significance | ZNF469-related disorder | 2023-12-09 | criteria provided, single submitter | clinical testing | The ZNF469 c.1609G>A variant is predicted to result in the amino acid substitution p.Val537Met. This variant was reported in individuals with keratoconus and corneal dystrophy (Lucas et al. 2017. PubMed ID: 29228253; Li et al. 2021. PubMed ID: 33816482). This variant is reported in 0.27% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Genome Diagnostics Laboratory, |
RCV000488174 | SCV001808486 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000488174 | SCV001967295 | likely benign | not provided | no assertion criteria provided | clinical testing |